Splenic artery occlusion for small‐for‐size syndrome: Better late than never but early is the best
Chung‐Mau Lo – 28 January 2009
Vascular endothelial growth factor receptor 2 expression in non‐tumorous cirrhotic liver is higher when hepatoma is beyond milan criteria
Federico Aucejo, Richard Kim, Nizar Zein, Cristiano Quintini, Teresa Diago Uso, Rocio Lopez, Bijan Eghtesad, John Fung, Charles Miller, Lisa Yerian – 28 January 2009 – Hepatocellular carcinoma (HCC) is a highly vascular tumor. Angiogenesis in HCC is mediated at least in part by vascular endothelial growth factor (VEGF), which is expressed in HCC and surrounding cirrhotic tissue.
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard‐dose or reduced‐dose tacrolimus in liver transplant recipients
Björn Nashan, Faouzi Saliba, Francois Durand, Rafael Barcéna, Jose Ignacio Herrero, Gilles Mentha, Peter Neuhaus, Matthew Bowles, David Patch, Angel Bernardos, Jürgen Klempnauer, René Bouw, Jane Ives, Richard Mamelok, Diane McKay, Matt Truman, Paul Marotta – 28 January 2009 – The pharmacokinetics of mycophenolate mofetil (MMF) in liver transplant recipients may change because of pharmacokinetic interactions with coadministered immunosuppressants or because changes in the enterohepatic anatomy may affect biotransformation of MMF to mycophenolic acid (MPA) and enterohepatic recirculation of M
The importance of hepatic encephalopathy: Pre‐transplant and post‐transplant
Andrea DiMartini, Kapil Chopra – 28 January 2009
Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation
Eva U. Sotil, Jeanne Gottstein, Edgar Ayala, Christopher Randolph, Andres T. Blei – 28 January 2009 – In the current Model for End‐Stage Liver Disease allocation system, patients are at risk of suffering repeated episodes of hepatic encephalopathy (HE) while waiting for an orthotopic liver transplantation (OLT); the posttransplantation impact of these episodes has not been well explored.
The transporter “variome”: The missing link between gene variants and bile salt transporter function
Roman Müllenbach, Frank Lammert – 28 January 2009
Reply:
George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis, Athanasios J. Archimandritis – 28 January 2009
Hepatitis B e antigen–negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu – 28 January 2009
East–West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma
Valeer J. Desmet – 28 January 2009